- Oops!Something went wrong.Please try again later.
More news today from Chinese officials has investors fearing what might be next for U.S.-traded Chinese companies.
What happened Shares of several COVID-19 vaccine makers were sliding on Monday. BioNTech stock (NASDAQ: BNTX) was down 6.5% at 12:09 p.m. EDT. Shares of Moderna (NASDAQ: MRNA) had slipped 4.4%. Novavax (NASDAQ: NVAX) stock had fallen 6%.
Brian Sozzi, Julie Hyman, and Brian Cheung break down Monday’s trending tickers which include: Tesla shareholders receiving a recommendation to reject Kimbal Musk and Murdoch as board members, Morgan Stanley cutting Amazon’s price target as concerns over the company’s profitability take center stage, and Polestar partnering with Gores Guggenheim in a SPAC deal to go public.
In this article, we reviewed Bridgewater Associates founder Ray Dalio’s portfolio adjustment strategies to cope up with the market volatility. We also discussed the top ten stocks billionaire Ray Dalio is buying. You can skip our detailed discussion and jump directly to Billionaire Ray Dalio is Buying These 5 Stocks. Raymond Thomas Dalio’s $223 billion […]
Computer systems design services company Nvidia (NASDAQ: NVDA) stock has delivered impressive gains of more than 70% so far this year, beating rival Advanced Micro Devices (NASDAQ: AMD) handsomely as investors have appreciated the graphics card specialist's robust revenue and earnings growth. In this article, we will look at the catalysts driving AMD's growth and check what makes it a better bet than Nvidia right now. Video game consoles have been in hot demand since last year.
The market's recent volatility may have you feeling skittish, but it has turned some good investing opportunities into even better deals.
The broad stock market might be near an all-time high, but game-changing companies C3.ai and Zillow certainly aren't.
Product shortages are generally bad for business -- unless you're in the business of making the product that's in short supply. It's for this reason that shares of semiconductor manufacturer Nvidia (NASDAQ: NVDA) -- a supplier of chips for everything from playing video games to mining cryptocurrency to performing artificial intelligence tasks -- have benefited so much from the global semiconductor shortage over the past couple of years, more than doubling in 2020 and gaining another 65% so far this year. Chipmakers are building new semiconductor plants, and planning to build even more, to capitalize on the global shortage of computer chips and the high prices that this has spawned.
The fascinating thing about General Electric (NYSE: GE), Johnson Controls (NYSE: JCI), and Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is that they have entirely different earnings drivers over the next decade. Former CEO Jeff Immelt has been widely criticized for making big bets on fossil fuel technologies. Unfortunately, the market for gas turbines halved in the years since the significant Alstom acquisition, as did the price of oil after Immelt made a slew of acquisitions.
Naked Brand Group Ltd (NASDAQ: NAKD) is continuing to trade higher Monday after the company's chairman and CEO, Justin Davis-Rice, stated Friday that the company had found an opportunity in clean technology. "I am happy to report that after extensive searching and due diligence, we believe we have found a disruptive opportunity in the clean technology sector. Due diligence on both sides is progressing and we believe the business combination will reward our patient shareholders," said Davis-Rice
Buying stocks can benefit investors of all ages. And the younger you are the more time is available for those investments to compound. But today's market full of biotech and artificial intelligence companies can be intimidating for those a little later in their investing journey.
With that in mind, we asked three Motley Fool contributors to highlight one stock that's already a tremendous run so far this year that they'd buy today. Danny Vena (Global-E Online): There's little doubt e-commerce has a long runway ahead. The company handles many of the challenges and complexities that come with international selling, leaving the merchant to go about their daily routine.
Red Cat Holdings Inc (NASDAQ: RCAT) subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission. The financial terms of the transaction remain undisclosed. NASA's crew would conduct simulated spacewalks and operations by remote piloting Skypersonic drones and rovers in a simulated Martian environment. Skypersonic's Dronebox real-time transoceanic remote piloting platform will drive the piloting of both
Morgan Stanley cut its price target on the stock, saying a push by Amazon to add to its logistics workforce was adding to profit pressures.
Here's why Wall Street thinks Teladoc stock could soar 44% higher within the next year. To be sure, several analysts expect that Teladoc Health will continue to face some headwinds this year. Teladoc recently signed a major agreement with Health Care Service Corporation (HCSC), the fifth-largest health insurer in the U.S., to provide chronic care solutions to HCSC members.
Dell Technologies (NYSE: DELL) shareholders are about to realize a corporate event they've been looking forward to for over a year now: the tax-free spinoff of Dell's 80.6% stake in virtualization software company VMware (NYSE: VMW). Dell's stock has already done quite well in 2021, up more than 40% on the year, in anticipation of the move. Last week, management held an analyst day, touting its outlook for the core business, as well as the future implementation of a large share repurchase plan and initiation of what looks to be a hefty future dividend.
One stock investors may be considering is pot producer Sundial Growers (NASDAQ: SNDL). In the wake of that decline, is Sundial Growers a bargain worth buying, or should investors steer clear? Sundial Growers is no exception.
Biotech stocks have been some of the most reliable capital-appreciation vehicles in the entire market for the past two decades. As proof, biotech equities such as CRISPR Therapeutics, Moderna, Novavax, Ocugen, and Vertex Pharmaceuticals -- just to name a few -- have all made their early shareholders market-crushing gains. Not all biotech stocks are cut from the same cloth, however.
Despite being one of the most recognizable wireless carriers in the U.S., AT&T stock has had a rough 2020. But the stock does have some perks. Is it a buy?
In this article, we examined legendary investor George Soros’ investment strategy and his historical performance. We also reviewed the 10 best stocks to buy according to George Soros. You can skip our detailed discussion and jump on directly to 5 Best Stocks to Buy According to George Soros. The legendary billionaire investor George Soros, 90, […]
If volatility is not your bag, then definitely stay away from Cassava Sciences (SAVA) stock. This biotech has been one of 2021’s most volatile, not to mention, controversial names. Ultimately, however, for those willing to shoulder the risk, a bet on Cassava at the start of the year has paid off – the stock is up by a huge 900% since 2021 began. That said, if you came on board toward the end of July, you’re probably sitting on some heavy losses, as the market has taken back a huge chunk of the p